CLINICAL_TRIALS
trial_result
· 2021-03-30
Clinical Trial Update: The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture [Phase 1, Phase 2]
Summary
A clinical trial update investigating the effect of semaglutide on bone turnover in individuals at increased risk of bone fracture, spanning Phase 1 and Phase 2…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Morten Frost | Conditions: Osteopenia | Phase 1, Phase 2 | Status: UNKNOWN